Amylyx Pharmaceuticals Inc (AMLX)
$28.86 +0.63% Close Oct 30, 2026 Live
Amylyx Pharmaceuticals stock today
Amylyx Pharmaceuticals closed at $28.86 on October 30, 2026, up 0.63% on the day. Over the past year it returned +105.4% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $3.21 billion.
$10.00$20.00$30.00$40.00
NovJan 2026MarMayJulSep
| Period | AMLX | S&P 500 (SPY) |
|---|---|---|
| 1 month | -0.8% | -0.9% |
| 3 months | +39.1% | +2.1% |
| Year to date | +138.9% | +11.7% |
| 1 year | +105.4% | +12.4% |
| 3 years | +83.2% | +88.5% |
Key statistics
- Market value
- $3.21B
- 52-week range
- $11.38 to $39.66
- Next report
- Nov 5, 2026
About Amylyx Pharmaceuticals
Develops and commercializes pharmaceutical drugs for neurodegenerative diseases.
Sector: Health Care
More on Amylyx Pharmaceuticals
- Financials: revenue, earnings and segmentsRevenue -77% in the year to Dec 2024
- Returns: what $1,000 became$1,000 three years ago is $1,832 today
No forecast, no recommendation. This page describes Amylyx Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.